Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis

Osteoporosis, an aging-associated bone metabolic disease, is affecting millions of people worldwide. The deregulated process of osteoblastic differentiation has been linked with the progression of osteoporosis. Trelagliptin is a long-acting inhibitor of DPP-4 used for the management of type 2 diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Haiyu, Wu, Renzheng, Cao, Li, Gu, Haifeng, Chai, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291811/
https://www.ncbi.nlm.nih.gov/pubmed/33734011
http://dx.doi.org/10.1080/21655979.2021.1900633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291811/
https://www.ncbi.nlm.nih.gov/pubmed/33734011
http://dx.doi.org/10.1080/21655979.2021.1900633

Ejemplares similares